It follows from previous studies that plasma NT-proBNP level is an important biomarker in predicting the prognosis of patients with CHF, especially for patients with diabetes (31), where NT-proBNP is closely related to the left ventricular reconstruction in CHF. This evidence concerns the gene NPPB and diabetes mellitus.